About SPDR S&P Biotech ETF (XBI)

The SPDR S&P Biotech ETF (XBI) is a widely-traded exchange-traded fund that provides investors with exposure to the biotechnology sector of the stock market. The ETF seeks to track the performance of the S&P Biotechnology Select Industry Index, which includes companies primarily involved in the research, development, and production of biological drugs and products. With a diverse portfolio of biotech companies, XBI offers investors the opportunity to participate in the potential growth of this innovative industry.

As of the latest quote, the price of XBI stands at $123.45. Investors can access real-time price updates and historical price charts to track the performance of the ETF. Analyzing the price history of XBI can provide insight into its volatility and potential for returns over time. Investors may consider the ETF's performance against its benchmark index and evaluate its consistency in delivering returns.